DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)



company name or ticker
Company Photos
(Click to zoom)

3 Big Healthcare Trends Wall Street Is Overlooking

Here's your chance to be one-up on Wall Street. Fools explain how the Street is missing key growth opportunities, as well as an important new threat to insurers.

Isis Pharmaceuticals: Another Regeneron (Or Even Better) In The Making?

Seeking Alpha's Biotech Weekly: Go, Go, Gilead, Sorrento's Celgene Challenge, And More

Merck (MRK) Presents Multiple Biosimilar and Diabetes Data - Analyst Blog

Merck (MRK) Presents Multiple Biosimilar and Diabetes Data - Analyst Blog

Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks

Why Drugmaker AbbVie Can Power Past Patent Expiration

3 Things AbbVie Inc.'s Management Wants You to Know

AbbVie's management team had a lot to talk about on their last investor conference call. Here are my three takeaways you need to know when considering the stock for investment.

Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 12, 2015

Regeneron/Sanofi's Praluent Gets Positive FDA Panel Vote - Analyst Blog

Biotech Stock Roundup: FDA Panel Recommends Regeneron's Praluent, SAGE Gains on Data - Analyst Blog

Biotech Stock Roundup: FDA Panel Recommends Regeneron's Praluent, SAGE Gains on Data - Analyst Blog
See More Articles...